Biosimilar infliximab versus originator in Crohn’s
disease anti-TNF-α naïve and non-naïve patients

Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients

Saved in:

Bibliographic Details
Main Authors:	Magdalena Kaniewska, Mariusz Rosołowski, Andrzej Moniuszko, Grazyna Rydzewska
Format:	Article
Language:	English
Published:	Termedia Publishing House 2020-11-01
Series:	Gastroenterology Review
Subjects:	inflammatory bowel disease crohn’s disease biological treatment biosimilar anti-tnf-α naïve infliximab.
Online Access:	https://www.termedia.pl/Biosimilar-infliximab-versus-originator-in-Crohn-s-r-ndisease-anti-TNF-naive-and-non-naive-patients,41,42377,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
by: Hesham M. El Mazar, et al.
Published: (2025-01-01)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
by: Magdalena Kaniewska, et al.
Published: (2019-12-01)

The efficacy and safety of the biosimilar product (Inflectra®) compared to the reference drug (Remicade®) in rescue therapy in adult patients with ulcerative colitis
by: Magdalena Kaniewska, et al.
Published: (2017-09-01)

Biosimilars in Focus: Evaluating Their Role Compared to Adalimumab in Clinical Practice
by: Dorota Waz, et al.
Published: (2025-01-01)

Efficiency and safety of one-year anti-TNF-α treatment in Crohn’s disease: a Polish single-centre experience
by: Marcin Sochal, et al.
Published: (2019-12-01)

Intestinal tissue levels of anti-TNF alpha, antibodies, and cytokines in paediatric Crohn disease
by: Vojtech Dotlacil, et al.
Published: (2025-01-01)

Heart failure in paediatric Crohn’s disease patient – extraintestinal manifestation, concomitant disease or iatrogenic effect?
by: Snehil Swaraj, et al.
Published: (2024-12-01)

Colonic strictures in Crohn’s disease: a non-surgical survival
by: Sarra Laabidi, et al.
Published: (2025-12-01)

The risk of small bowel adenocarcinoma in patients with Crohn’s disease
by: Gustaw Lech, et al.
Published: (2020-12-01)

Inflammatory Bowel Diseases in Children: Modern Achievements in Diagnostics and Therapy
by: A. I. Khavkin, et al.
Published: (2024-01-01)

Anthocyanins from purple corn affect gut microbiota and metabolome in inflammatory bowel disease patients under infliximab infusion: the SiCURA pilot study
by: Mirco Vacca, et al.
Published: (2024-11-01)

Adalimumab induced psoriasis in Crohn’s disease and treatment with ustekinumab: case report and special histopathological findings
by: Fang Qiu, et al.
Published: (2025-01-01)

Features of Crohn's Disease Depending on the Age of Disease Onset
by: E. G. Ganich, et al.
Published: (2023-12-01)

α-Methyl-Tryptophan Inhibits SLC6A14 Expression and Exhibits Immunomodulatory Effects in Crohn’s Disease
by: Su Y, et al.
Published: (2025-01-01)

Analysis of risk factors of Clostridioides difficile infection in patients with inflammatory bowel disease
by: Alicja Jakubowska, et al.
Published: (2024-09-01)

Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01)

Superior persistence of ustekinumab compared to anti-TNF in vedolizumab-experienced inflammatory bowel diseases patients: a real-world cohort study
by: Horng-Yih Chiu, et al.
Published: (2024-12-01)

Perceptions of Biosimilars Among Healthcare Providers in Saudi Arabia
by: Mohammed Alqahtani, et al.
Published: (2024-11-01)

Nonclinical Similarity of the Biosimilar Candidate ABP 938 with Aflibercept Reference Product
by: Neungseon Seo, et al.
Published: (2024-11-01)

Therapeutic drug monitoring and neutralizing anti-drug antibody detection to optimize TNF-alpha inhibitor treatment for uveitis
by: Howard C. Chen, et al.
Published: (2025-01-01)

Improved incremental algorithm of Naive Bayes
by: Shui-fei ZENG, et al.
Published: (2016-10-01)

Application of Spectral Computed Tomography Single-energy Technique to Small Bowel Crohn’s Disease
by: Pengfei WU, et al.
Published: (2025-01-01)

Management of anemia in inflammatory bowel disease: a challenge in everyday clinical practice
by: Edyta Tulewicz-Marti, et al.
Published: (2017-12-01)

The pro-inflammatory cytokine Tumor Necrosis Factor alpha (TNF-α) in Diabetic Nephropathy
by: Alia KH Mahmoud, et al.
Published: (2024-07-01)

Study on an improved naive Bayes algorithm in spam filtering
by: Lei YANG, et al.
Published: (2017-04-01)

AhR Activation Transcriptionally Induces Anti-Microbial Peptide Alpha-Defensin 1 Leading to Reversal of Gut Microbiota Dysbiosis and Colitis
by: Manikandan Palrasu, et al.
Published: (2025-12-01)

Research of a spam filter based on improved naive Bayes algorithm
by: 曹翠玲, et al.
Published: (2017-03-01)

Ulcerative colitis: STRIDE-ing beyond symptoms with new standards
by: Shu Wen Tay, et al.
Published: (2024-02-01)

A review of the types of diets used in Crohn’s disease: the support system for pharmacological treatment
by: Joanna Śnieżna, et al.
Published: (2025-01-01)

Study of Brain-derived Neurotrophic Factor in Drug-naive Patients with Schizophrenia
by: Partik Kaur, et al.
Published: (2024-05-01)

The role of major virulence factors and pathogenicity of adherent-invasive Escherichia coli in patients with Crohn’s disease
by: Khalid A. Abdelhalim, et al.
Published: (2020-12-01)

Pooled Multicenter Safety Analysis of Lupin’s Intravitreal Biosimilar Ranibizumab (Ranieyes) in Chorioretinal Vascular Diseases
by: Debdulal Chakraborty, et al.
Published: (2024-11-01)

Anti-Tumor Necrosis Factor-α Use in Pediatric Inflammatory Bowel Disease—Reports from a Romanian Center
by: Roxana Matran, et al.
Published: (2025-01-01)

Management of Anal Fistula with Crohn's Disease
by: Shota Takano, et al.
Published: (2025-01-01)

New Possibilities for the Treatment of Crohn’s Disease
by: Z. A. Mamieva, et al.
Published: (2019-12-01)

Effective low-cost pediatric vision screening by naive nonophthalmic examiners using the ‘Arclight’ device
by: Rujuta Gore, et al.
Published: (2025-01-01)

An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
by: Hongzhen Wu, et al.
Published: (2025-01-01)

Management of anaemia in patients with inflammatory bowel disease – results of a questionnaire among Polish healthcare professionals
by: Edyta M. Tulewicz-Marti, et al.
Published: (2021-03-01)

Guidelines for the management of patients with Crohn’s disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology
by: Michał Łodyga, et al.
Published: (2021-11-01)

Application of a naive Bayesians classifiers in assessing the supplier
by: Mijailović Snežana, et al.
Published: (2017-01-01)